AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2017
Mar 10, 2017
29755_dirs_2017-03-10_cef34e7d-175c-40cb-b1e7-7e17a2944da4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-03-10
Reporting Person: Schumacher Laura J (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-10 | Common stock, $0.01 par value | S | 410 | $65.11 | Disposed | 147415 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 100 | $65.13 | Disposed | 147315 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 757 | $65.16 | Disposed | 146558 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 100 | $65.17 | Disposed | 146458 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 100 | $65.20 | Disposed | 146358 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 9696 | $65.21 | Disposed | 136662 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 300 | $65.22 | Disposed | 136362 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 230 | $65.24 | Disposed | 136132 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 15491 | $65.27 | Disposed | 120641 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 2300 | $65.28 | Disposed | 118341 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 9816 | $65.29 | Disposed | 108525 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 100 | $65.299 | Disposed | 108425 | Direct |
| 2017-03-10 | Common stock, $0.01 par value | S | 600 | $65.30 | Disposed | 107825 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4